Medical News

---

• Prophylactic antibiotic regimens lack evidence of PARITY
• Promising results for dabrafenib in advanced melanoma
• Psoriasis link with autoimmune diseases underscored
• Aspirin bleeding risk ‘higher than expected’ in primary prevention
• Aspirin bleeding risk ‘higher than expected’ in primary prevention

Prophylactic antibiotic regimens lack evidence of PARITY Posted: 07 Jun 2012 05:00 PM PDT Results from the PARITY study highlight the need for consensus in the prevention of infection in patients undergoing endoprosthetic limb reconstruction following sarcoma.

Promising results for dabrafenib in advanced melanoma Posted: 07 Jun 2012 05:00 PM PDT The BRAF inhibitor dabrafenib shows promising results for treatment of advanced melanoma, both alone and in combination with the MEK inhibitor trametinib, show results from two studies presented at the American Society of Clinical Oncology Annual Meeting in Chicago, Illinois, USA.

Psoriasis link with autoimmune diseases underscored Posted: 07 Jun 2012 05:00 PM PDT Patients with psoriasis are nearly twice as likely to have an autoimmune disease as individuals without the condition, suggest study findings.

Aspirin bleeding risk ‘higher than expected’ in primary prevention Posted: 06 Jun 2012 05:00 PM PDT A new analysis of aspirin use for primary prevention of cardiovascular disease suggests it is associated with higher risks for gastrointestinal or cerebral bleeding episodes than previously thought.

Aspirin bleeding risk ‘higher than expected’ in primary prevention Posted: 06 Jun 2012 05:00 PM PDT A new analysis of aspirin use for primary prevention of cardiovascular disease suggests it is associated with higher risks for gastrointestinal or cerebral bleeding episodes than previously thought.

You are subscribed to email updates from MedWire Medical News Combined Feed To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610